FIELD: biotechnology, medicine, oncology.
SUBSTANCE: invention relates to peptides found by selection of phage peptide library by a feature for selective binding with target-cells. These peptides are able to accumulate in lung adenocarcinoma cells and show the following amino acid sequences: RNVPPIFNDVYWIAF, SVAILPRSFSPFXVG, PFARAPVEHHDVVGL. New tumor-targeted peptides allow carrying out the purposeful delivery of preparation of different designation to lung adenocarcinoma cells. Invention can be used in medicine in treatment and diagnosis of lung adenocarcinoma and its metastasis.
EFFECT: valuable medicinal properties of peptides.
2 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TUMOR-TARGETED PEPTIDE | 2003 |
|
RU2265027C2 |
| TUMOUR-SPECIFIC PEPTIDE FOR ADDRESS CHEMOTHERAPY OF HUMAN BREAST CANCER | 2015 |
|
RU2595404C1 |
| PEPTIDE-SIMULATOR OF PROTEIN GP120 HIV-1 EPITOPE | 2000 |
|
RU2184780C2 |
| PEPTIDE-SIMULATOR OF HUMAN IMMUNODEFICIENCY TYPE-1 VIRUS PROTEIN GP41 CONSERVATIVE EPITOPE RECOGNIZED BY VIRUS-NEUTRALIZING MONOCLONAL ANTIBODY 2F5 (VARIANTS) | 2000 |
|
RU2179980C2 |
| IMMUNOMIMETIC PEPTIDE OF CHEMICAL CANCEROGENS WITH SPECIFIC INTERACTION EFFECT ON ANTIBODIES OF BENZO[α]PYRENE AND BENZO[α]ANTHRACENE | 2007 |
|
RU2357975C1 |
| NEW ANTIBODY SHOWING SPECIFICITY TO MALIGNANT LARGE INTESTINE TUMOR | 2001 |
|
RU2268068C2 |
| AGENT FOR NEUTRALISING SMALLPOX VIRUS | 2013 |
|
RU2515905C1 |
| RECOMBINANT FRAGMID DNA pHEN-TAB CONTAINING HUMAN SINGLE-STRAND ANTIBODY GENE, CAPABLE OF BINDING OF HUMAN TUMOR NECROSIS FACTOR ALPHA; RECOMBINANT Escherichia coli BACTERIA STRAIN AS PRODUCER OF HUMAN SINGLE-STRAND ANTIBODY AGAINST HUMAN TUMOR NECROSIS FACTOR ALPHA; RECOMBINANT SOLUBLE HUMAN SINGLE-STRAND ANTIBODY AGAINST HUMAN TUMOR NECROSIS FACTOR ALPHA | 2005 |
|
RU2307163C2 |
| ANTIBODY RAISED AGAINST TO HUMAN GASTROENTERIC TRACT EPITHELIAL TUMOR ANTIGEN RELATED WITH ALPHA-6,BETA-4-INTEGRIN | 2000 |
|
RU2266298C2 |
| SINGLE-DOMAIN MINI-ANTIBODY aHER2/aSKBR3-1, SPECIFICALLY BINDING EPIDERMAL GROWTH FACTOR RECEPTOR HER2/ERBB2/neu AND CAPABLE TO PENETRATE THROUGH THIS INTERACTION INTO TARGET CELLS (INTERNALISED), METHOD OF PRODUCTION OF THIS ANTIBODY AND METHOD OF DETECTION OF PROTEIN HER2/ERBB2/neu AND CELLS EXPRESSING THIS PROTEIN IN INCREASED AMOUNT, USING MINI-ANTIBODY aHER2/aSKBR3-1 | 2012 |
|
RU2522929C2 |
